Literature DB >> 20008164

Myoferlin is required for insulin-like growth factor response and muscle growth.

Alexis R Demonbreun1, Avery D Posey, Konstantina Heretis, Kayleigh A Swaggart, Judy U Earley, Peter Pytel, Elizabeth M McNally.   

Abstract

Insulin-like growth factor (IGF) is a potent stimulus of muscle growth. Myoferlin is a membrane-associated protein important for muscle development and regeneration. Myoferlin-null mice have smaller muscles and defective myoblast fusion. To understand the mechanism by which myoferlin loss retards muscle growth, we found that myoferlin-null muscle does not respond to IGF1. In vivo after IGF1 infusion, control muscle increased myofiber diameter by 25%, but myoferlin-null muscle was unresponsive. Myoblasts cultured from myoferlin-null muscle and treated with IGF1 also failed to show the expected increase in fusion to multinucleate myotubes. The IGF1 receptor colocalized with myoferlin at sites of myoblast fusion. The lack of IGF1 responsiveness in myoferlin-null myoblasts was linked directly to IGF1 receptor mistrafficking as well as decreased IGF1 signaling. In myoferlin-null myoblasts, the IGF1 receptor accumulated into large vesicular structures. These vesicles colocalized with a marker of late endosomes/lysosomes, LAMP2, specifying redirection from a recycling to a degradative pathway. Furthermore, ultrastructural analysis showed a marked increase in vacuoles in myoferlin-null muscle. These data demonstrate that IGF1 receptor recycling is required for normal myogenesis and that myoferlin is a critical mediator of postnatal muscle growth mediated by IGF1.-Demonbreun, A. R., Posey, A. D., Heretis, K., Swaggart, K. A., Earley, J. U., Pytel, P., McNally, E. M. Myoferlin is required for insulin-like growth factor response and muscle growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008164      PMCID: PMC2845429          DOI: 10.1096/fj.09-136309

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

Authors:  S A Coolican; D S Samuel; D Z Ewton; F J McWade; J R Florini
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

2.  Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle.

Authors:  D Edwall; M Schalling; E Jennische; G Norstedt
Journal:  Endocrinology       Date:  1989-02       Impact factor: 4.736

3.  Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.

Authors:  R W Furlanetto
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

4.  IGF-I is required for normal embryonic growth in mice.

Authors:  L Powell-Braxton; P Hollingshead; C Warburton; M Dowd; S Pitts-Meek; D Dalton; N Gillett; T A Stewart
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

5.  Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1 or insulin-like growth factor I.

Authors:  J P Lefaucheur; A Sébille
Journal:  J Neuroimmunol       Date:  1995-03       Impact factor: 3.478

6.  Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts.

Authors:  A Zapf; D Hsu; J M Olefsky
Journal:  Endocrinology       Date:  1994-06       Impact factor: 4.736

7.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).

Authors:  J P Liu; J Baker; A S Perkins; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice.

Authors:  M E Coleman; F DeMayo; K C Yin; H M Lee; R Geske; C Montgomery; R J Schwartz
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

9.  Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.

Authors:  E M McNally; D Duggan; J R Gorospe; C G Bönnemann; M Fanin; E Pegoraro; H G Lidov; S Noguchi; E Ozawa; R S Finkel; R P Cruse; C Angelini; L M Kunkel; E P Hoffman
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

10.  Homotypic fusion between aggregated lysosomes triggered by elevated [Ca2+]i in fibroblasts.

Authors:  A C Bakker; P Webster; W A Jacob; N W Andrews
Journal:  J Cell Sci       Date:  1997-09       Impact factor: 5.285

View more
  31 in total

Review 1.  Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair.

Authors:  Angela Lek; Frances J Evesson; R Bryan Sutton; Kathryn N North; Sandra T Cooper
Journal:  Traffic       Date:  2011-09-06       Impact factor: 6.215

2.  Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.

Authors:  Anuradha Balasubramanian; Genri Kawahara; Vandana A Gupta; Anete Rozkalne; Ariane Beauvais; Louis M Kunkel; Emanuela Gussoni
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

3.  Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling.

Authors:  Ann-Katrin Piper; Samuel E Ross; Gregory M Redpath; Frances A Lemckert; Natalie Woolger; Adam Bournazos; Peter A Greer; Roger B Sutton; Sandra T Cooper
Journal:  Cell Signal       Date:  2017-02-10       Impact factor: 4.315

4.  Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.

Authors:  Alexis R Demonbreun; Ann E Rossi; Manuel G Alvarez; Kaitlin E Swanson; H Kieran Deveaux; Judy U Earley; Michele Hadhazy; Ravneet Vohra; Glenn A Walter; Peter Pytel; Elizabeth M McNally
Journal:  Am J Pathol       Date:  2013-10-29       Impact factor: 4.307

Review 5.  Ferlin proteins in myoblast fusion and muscle growth.

Authors:  Avery D Posey; Alexis Demonbreun; Elizabeth M McNally
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

6.  EHD1 mediates vesicle trafficking required for normal muscle growth and transverse tubule development.

Authors:  Avery D Posey; Kaitlin E Swanson; Manuel G Alvarez; Swathi Krishnan; Judy U Earley; Hamid Band; Peter Pytel; Elizabeth M McNally; Alexis R Demonbreun
Journal:  Dev Biol       Date:  2014-01-17       Impact factor: 3.582

7.  Myoferlin regulation by NFAT in muscle injury, regeneration and repair.

Authors:  Alexis R Demonbreun; Karen A Lapidos; Konstantina Heretis; Samantha Levin; Rodney Dale; Peter Pytel; Eric C Svensson; Elizabeth M McNally
Journal:  J Cell Sci       Date:  2010-06-22       Impact factor: 5.285

8.  Mechanistic modeling of the effects of myoferlin on tumor cell invasion.

Authors:  Marisa C Eisenberg; Yangjin Kim; Ruth Li; William E Ackerman; Douglas A Kniss; Avner Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

9.  Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion.

Authors:  Avery D Posey; Peter Pytel; Konstantina Gardikiotes; Alexis R Demonbreun; Mark Rainey; Manju George; Hamid Band; Elizabeth M McNally
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 10.  Plasma Membrane Repair in Health and Disease.

Authors:  Alexis R Demonbreun; Elizabeth M McNally
Journal:  Curr Top Membr       Date:  2015-11-27       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.